Fewer Intubations but Higher Mortality Among Intubated Coronavirus Disease 2019 Patients During the Second Than the First Wave
OBJECTIVES:. Since changes in pharmacological treatments for severely ill patients with coronavirus disease 2019 have been incorporated into clinical practice, both by their use (corticosteroids and remdesivir) and by stopping them (e.g., hydroxychloroquine), we sought to compare the rate of intubat...
Guardado en:
Autores principales: | Christina Routsi, MD, PhD, Stelios Kokkoris, MD, PhD, Ilias Siempos, MD, PhD, Eleni Magira, MD, PhD, Anastasia Kotanidou, MD, PhD, Spyros Zakynthinos, MD, PhD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d066d43d214444f48716f0bc7f16731f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of Aggravation-Predicting Gene Polymorphisms in Coronavirus Disease 2019 Patients Using a Candidate Gene Approach Associated With Multiple Phase Pathogenesis: A Study in a Japanese City of 1 Million People
por: Naoki Tanimine, MD, PhD, et al.
Publicado: (2021) -
Interleukin-6 in Critical Coronavirus Disease 2019, a Driver of Lung Inflammation of Systemic Origin?
por: Nikolai Ravn Aarskog, MD, et al.
Publicado: (2021) -
Detectable A Disintegrin and Metalloproteinase With Thrombospondin Motifs-1 in Serum Is Associated With Adverse Outcome in Pediatric Sepsis
por: Navin P. Boeddha, MD, PhD, et al.
Publicado: (2021) -
Effect of Inhaled Xenon on Cardiac Function in Comatose Survivors of Out-of-Hospital Cardiac Arrest—A Substudy of the Xenon in Combination With Hypothermia After Cardiac Arrest Trial
por: Antti Saraste, MD, PhD, et al.
Publicado: (2021) -
Paving the Road for the Adoption of Normothermic Regional Perfusion in Canada
por: John Basmaji, MD, et al.
Publicado: (2021)